1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsMyasthenia Gravis Network (MGNet) Scholar Program is sponsored by Rare Diseases Clinical Research Network. The MGNet Scholar Program provides mentored research training to prepare scholars for an independent research career in the field of Myasthenia Gravis (MG).
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Home | The Myasthenia Gravis Rare Disease Network An NIH-Funded Rare Diseases Clinical Research Network Consortium Enhancing discovery and treatment for the myasthenia gravis patient community.
Join One of Our Research Studies Participants make it possible for researchers to find new treatments, speed diagnosis, and improve the lives of those affected by rare diseases Learn About Diseases We Study Rare Research Report: April 2026 Each month, we share summaries of recent Rare Diseases Clinical Research Network grant-funded publications. Catch up on RDCRN research for April 2026.
MGNet Announces 2026 Pilot Grant Award Recipient The Myasthenia Gravis Rare Disease Network (MGNet) has awarded the 2026 MGNet Pilot Award to Marina Chiara Garassino, MD. MGNet Announces 2026 Scholar The Myasthenia Gravis Rare Disease Network (MGNet) has awarded the 2026 MGNet Scholar Award to Fatemeh Khani-Habibabadi, PhD. Learn More About Myasthenia Gravis Access educational materials, frequently asked questions, lectures, and more.
Welcome to the MGNet Minute! Knowing Whether You’re Acetylcholine Receptor Antibody Positive Watch All of the MGNet Minute Videos Newsletter of the Myasthenia Gravis Rare Disease Network MGNet Newsletter Consortium Updates
According to the current listing, eligibility includes: Applicants must have an MD (or equivalent) or PhD. Clinical fellows, post-doctoral fellows, or junior faculty are eligible. Confirm the full requirements in the official notice before applying.
The current listing shows up to $75,000 per year, plus 10% indirect costs (After year one, scholars are encouraged to transition to NIH, departmental or private foundation support, or to compete for a second year of funding after submission of a second application that includes a description of accomplishments and pilot data). Verify award ceilings, matching requirements, and allowable costs in the official notice.
Myasthenia Gravis Network (MGNet) Scholar Program is funded by Rare Diseases Clinical Research Network. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
PAR-27-056 replaces the long-running IDeA-CTR U54 cooperative agreement with a P30 center core grant and splits the program into Development and Network tracks. Posted August 19, 2026, with a first estimated due date of October 9. Here is what the mechanism swap actually changes for the 23 IDeA states and Puerto Rico.
Read articleAt CGI on September 23, 2026, Global Impact Ventures committed $100 million over three years across economic opportunity, health, education, climate resilience and humanitarian needs. There is no application portal. The access route is the intermediary infrastructure — fiscal sponsorship, grantmaking administration, and a 250-organization network.
Read articleNOT-OD-26-098 consolidates NIH career development awards into four parent NOFOs (KR1, KC1, KS1, KT1), eliminates the Data Management and Sharing Plan for K applications, and stops supporting K awards that let the awardee lead their own clinical trial. The RFI closes September 30, 2026; the new structure hits due dates on or after October 12, 2027.
Read article